Physician profile

Stephen Koryo An

Foot & Ankle Surgery · Palo Alto, CA

NPI 1467835991

$9,784.08

in general payments reported to CMS, 2019-2025

37 companies · $657 in 2025

The $657 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,670.39
Travel and Lodging$1,251.87

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $1,500.16 2019-2025 Collagenase Santyl, Stravix, Stravix Pl
Arthrex, INC. $1,202.10 2023
Arthrosurface Incorporated $1,120.00 2019
Musculoskeletal Transplant Foundation INC. $929.78 2019-2023
Zimmer Biomet Holdings, INC. $918.26 2019-2022
Evolution Surgical, INC $586.16 2023
Paratek Pharmaceuticals, INC. $562.18 2021-2025 Nuzyra
Organogenesis INC. $263.68 2020-2023 Puraply
Treace Medical Concepts, INC. $238.78 2019-2025
Nevro Corp. $227.37 2022-2023 Senza
Exactech, INC. $212.75 2024
Integra Lifesciences Corporation $183.79 2019-2020
Alafair Biosciences, INC. $176.88 2024-2025 Versawrap
Acell, INC. $154.92 2020
Osiris Therapeutics INC. $123.18 2019
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Kci USA, INC. $122.19 2020
Horizon Therapeutics Plc $114.75 2019-2023 Krystexxa
Wright Medical Technology, INC. $112.44 2019-2020
Curonix LLC $110.70 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Stryker Corporation $100.84 2024-2025 Ortholoc 2 Lapifuse, Prostep, Easyfuse
Paragon 28, INC. $100.20 2019-2022
Medical Device Business Services, INC. $90.25 2019
Averitas Pharma INC. $87.61 2024-2025 Qutenza
Depuy Synthes Sales INC. $72.95 2024-2025 Va-Lcp, Motoband Cp, Motoband
Amgen INC. $69.37 2024-2025 Krystexxa
Biotissue Holdings INC. $60.61 2023-2024
Vertex Pharmaceuticals Incorporated $58.16 2024-2025
Ani Pharmaceuticals, INC. $55.38 2025 Purified Cortrophin Gel
Ortho Dermatologics, A Division of Bausch Health US, LLC $43.75 2020
Zyla Life Sciences, INC. $30.27 2019
Bioventus LLC $26.13 2025 Exogen Ultrasound Bone Healing System
Amniox Medical, INC. $24.53 2020
Fidia Pharma USA INC. $23.80 2020
Kerecis Limited $22.57 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose
Reprise Biomedical, INC. $21.47 2025 Miro3d
Avita Medical Americas, LLC $20.10 2024
Bone Support INC. $16.02 2025 Cerament G, Ceramentbone Void Filler

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Stephen Koryo An

$9,784.08

in general payments reported 2019-2025

Years
2019-2025
Top company
Smith+Nephew, INC.
Context
The $657 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/1329784/stephen-koryo-an

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.